Novo Nordisk A/s

Jesper Soendergaard Pedersen

Svend Havelund

Morten Schlein

Mathias Norrman

Dorte Bjerre Steensgaard

Susanne Hostrup

Holger Martin Strauss

Rosa Rebecca Erritzoee Hansen

The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analogue, and to the medical use of such compositions for basal insulin administration therapy.

Insulin containing pharmaceutical compositions

The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analog, and to the medical use of such compositions for basal insulin administration therapy.

Growing community of inventors

Oelstykke, Denmark

Jesper Soendergaard Pedersen